Literature DB >> 24759714

Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.

Catherine Eckert1, Eleonore Holscher2, Amandine Petit3, Valérie Lalande4, Frédéric Barbut4.   

Abstract

The AmpliVue Clostridium difficile assay and a glutamate dehydrogenase (GDH)-illumigene algorithm were evaluated using 308 diarrheal stool specimens of patients suspected of having C. difficile infection. Compared to the enriched toxigenic culture method, the sensitivities, specificities, and positive and negative predictive values of the AmpliVue C. difficile assay and the GDH-illumigene-based algorithm were 91.7% (95% confidence interval [CI], 76.4 to 97.8), 100% (95% CI, 98.3 to 100), 100% (95% CI, 87 to 100), and 98.9% (95% CI, 96.6 to 99.7), respectively.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24759714      PMCID： PMC4097749          DOI： 10.1128/JCM.00353-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.

Authors:  Pierre René; Charles P Frenette; Ian Schiller; Nandini Dendukuri; Paul Brassard; Susan Fenn; Vivian G Loo
Journal:  Diagn Microbiol Infect Dis       Date:  2012-03-15       Impact factor: 2.803

2.  Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.

Authors:  E Deak; S A Miller; R M Humphries
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

3.  Reference assays for Clostridium difficile infection: one or two gold standards?

Authors:  Timothy Planche; Mark Wilcox
Journal:  J Clin Pathol       Date:  2010-11-30       Impact factor: 3.411

Review 4.  The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis.

Authors:  N Shetty; M W D Wren; P G Coen
Journal:  J Hosp Infect       Date:  2010-12-08       Impact factor: 3.926

5.  Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.

Authors:  Frédéric Barbut; Béatrice Gariazzo; Laetitia Bonné; Valérie Lalande; Béatrice Burghoffer; Ralucca Luiuz; Jean-Claude Petit
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-24       Impact factor: 3.254

6.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

7.  Clostridium difficile toxinotype XI (A-B-) exhibits unique arrangement of PaLoc and its upstream region.

Authors:  Barbara Geric Stare; Maja Rupnik
Journal:  Anaerobe       Date:  2010-04-20       Impact factor: 3.331

8.  Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.

Authors:  Valérie Lalande; Laurence Barrault; Sophie Wadel; Catherine Eckert; Jean-Claude Petit; Frédéric Barbut
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

Review 9.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).

Authors:  M J T Crobach; O M Dekkers; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

10.  Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

Authors:  T W Chang; S L Gorbach; J B Bartlett
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441
View more
  5 in total

Review 1.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

2.  A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.

Authors:  Martina Neuendorf; Raquel Guadarrama-Gonzalez; Birgit Lamik; Colin R MacKenzie
Journal:  BMC Microbiol       Date:  2016-02-12       Impact factor: 3.605

3.  A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults.

Authors:  Colleen S Kraft; J Scott Parrott; Nancy E Cornish; Matthew L Rubinstein; Alice S Weissfeld; Peggy McNult; Irving Nachamkin; Romney M Humphries; Thomas J Kirn; Jennifer Dien Bard; Joseph D Lutgring; Jonathan C Gullett; Cassiana E Bittencourt; Susan Benson; April M Bobenchik; Robert L Sautter; Vickie Baselski; Michel C Atlas; Elizabeth M Marlowe; Nancy S Miller; Monika Fischer; Sandra S Richter; Peter Gilligan; James W Snyder
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

4.  Comparison of a novel chemiluminescent based algorithm to three algorithmic approaches for the laboratory diagnosis of Clostridium difficile infection.

Authors:  J Goret; J Blanchi; C Eckert; S Lacome; A Petit; F Barbut; C Bébéar; Francis Mégraud
Journal:  Gut Pathog       Date:  2015-12-23       Impact factor: 4.181

Review 5.  Advanced DNA-Based Point-of-Care Diagnostic Methods for Plant Diseases Detection.

Authors:  Han Yih Lau; Jose R Botella
Journal:  Front Plant Sci       Date:  2017-12-06       Impact factor: 5.753
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.